Article
The Promise of Polygenic Risk Prediction in Smoking Cessation: Evidence From Two Treatment Trials
14 Feb 2022
Abstract excerpt
INTRODUCTION: Tobacco use disorder is a complex behavior with a strong genetic component. Genome-wide association studies (GWAS) on smoking behaviors allow for the creation of polygenic risk scores (PRSs) to approximate genetic vulnerability. However, the utility of smoking-related PRSs in predicting smoking cessation in clinical trials remains unknown. AIMS AND METHODS: We evaluated the association between...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
